Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
mycophenolate (CellCept) (2 trials)
tacrolimus (prograf) (2 trials)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
cytarabine (cytosar-u) (1 trial)
daunorubicin (cerubidine) (1 trial)
fludarabine (fludara) (1 trial)
quizartinib (VANFLYTA) (1 trial)
Graft vs Host Disease (Phase 3)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)
Trials (4 total)
Trial APIs (7 total)